Picture [LSUS] – The Business Web Portal 650x65px
Document › Details

OSE Pharma S.A.. (9/1/15). "Press Release: OSE Pharma Sets Up Scientific Steering Committee and Takes a First Step in the Launch of Its Phase 3 Trial in Lung Cancer [Not for US, CA, AU or JP]". Paris.

Organisations Organisation OSE Pharma S.A.
  Today OSE Immunotherapeutics S.A.
  Group OSE Immunotherapeutics (Group)
  Organisation 2 Institut Gustave Roussy (IGR)
Products Product Tedopi® cancer immunotherapy
  Product 2 clinical research
Persons Person Costantini, Dominique (OSE Pharma 201504 CEO + Co-founder + former CEO + Co-founder of BioAlliance Pharma in 1997)
  Person 2 Bault, Laurence (Huntsworth 201506 at Citigate Dewe Rogerson Paris)

Record changed: 2019-04-26


Picture [LSUS] – The Business Web Portal 650x65px

More documents for OSE Immunotherapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top